You are here

Home » Content

“Role of Nitric Oxide in Liver Cirrhosis”

Journal Name:

  • Indian Journal of Basic & Applied Medical Research

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
Introduction: Patients of liver cirrhosis suffer from deleterious effects of hyper dynamic circulation like ascites, edema etc. Increased Nitric Oxide levels may be one of the causes of them (potent vasodilator). So we have decided to study the role of Nitric Oxide in liver cirrhosis. Materials and Methods : The Nitric Oxide levels was found in the form of Total Nitrates in 40 normal controls and 40 known cases of liver cirrhosis by Cortas and Wakid method and compared it with liver functions like serum ALT activity (Kinetic Kit method), serum albumin level (Bromocresol Green method) and prothrombin time (Quick’s method) in both groups. Observations and Results; We found that the serum Nitric Oxide levels in the form of Total Nitrates were significantly high in liver cirrhosis patients (102 ± 20.3μmol/ L) as compared to normal controls (57 ± 19.9μmol/L), but having no co-relation with liver functions like serum albumin levels, serum total ALT levels and prothtrombin time. Conclusion; This study provides the evidence that increased production of Nitric Oxide in liver cirrhosis may be responsible for the hemodynamic changes seen in patients of liver cirrhosis. So by using Nitric Oxide inhibitors patient’s discomfort due to hyper dynamic circulation can be reduced.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon 546-550.pdf
  • 6
546-550
  • English

REFERENCES

References: 

1. Chu C J, Lee F Y, Wang S S, Chang F Y, Tsai Y T. Hyper
dynamic Circulation of Cirrhotic Rats: Role of Nitric Oxide.
Scand J Gastroenterol.1997 Aug; 32(8):841-6.
2. Harrison T R, Resnik W R, Wintrobe M M, Thorn G W,
Adams R D. Cirrhosis and its complications. Harrison’s
principles of Internal Medicine, 16th edition; volume II: 1483,
1865.
3. Gattoni A, Marotta F, Vangieri B, Pisani G, Cristiano F.
Hepatorenal Syndrome Clin. Ter. 2004 Sep; 155(9): 361-62.
4. Wei C L, Hon W M. Lee K H, Khoo H E. Chronic
Administration of Aminoguanidine Reduces Vascular Nitric
Oxide Production and Attenuates Liver Damage In Bile Duct
Ligated Rats. Liver Int.2005 Jun; 25(3):647-56.
Indian Journal of Basic & Applied Medical Research; March 2013: Issue-6, Vol.-2, P. 546-550
549
www.ijbamr.com
5. Kaplan L A, Pesce A J, Kazmierczak S C. Liver Function. Clinical Chemistry Theory, Analysis,
Correlation. 4th edition; 27:504.
6. Cortas N K and Wakid N W. Determination of Inorganic Nitrates in Serum and Urine by a Kinetic
Cadmium-Reduction method. Clinical Chemistry, 1990; 36/8:1440-43.
7. Coskun U, Ozenirler S, Sancak B, Bukan N. Serum and Ascitic Fluid Nitrates Levels in Patients with
Cirrhosis. Clin Chem Acta.2001 Apr, 306(1-2):127-32.
8. Vallance P, Moncada S. Hyperdynamic Circulation in Cirrhosis: a role of nitric oxide? The Lancet
1991.337(8744):776-778.
9. Tietz N W. Textbook of Clinical Chemistry, W B Saunders, 1986; 589
10. Bhagvan N.V. Protein and Amino Acid Metabolism. Medical Biochemistry, 4th Edition; 17:345.
11. Heidebaugh J J, Brudevly M. Cirrhosis and chronic liver failure: Part I Diagnosis and evaluation. Am Fam
Physician. 2006 Sep 1; 74(5):756-762.
12. Cao H, Wu Z, Zang X, Chen Z, Kuang Y. The role of vasoactive substances in hyperhemodynamics after
orthotropic liver transplantation in cirrhotic rats. Chin Med J (Engl). 2003 Mar; 116(3):405-9.
13. Marcus A R, Murray O, David Z, Sidney S S, Irwin W, Adrian V C. Albumin synthesis in cirrhotic subjects
with ascites studies with Carbonte-14 C. JCI, J Clin Invest. 1969; 48(2) 344-50.
14. Yokomori H, Oda M, Sakai K, Ishii H. Enhanced Expression Of Endothelial Nitric Oxide Synthase and
Caveolin-1 in Human Cirrhosis. Liver 2002 Apr; 22(2):150-8.
15. Fierbinteanu- Braticevici C, Udeanu N, Usvat R, Andronescu D. The Role of Octreotide on Renal Function
in Patients with Advanced Cirrhosis. Rom J Intern Med. 2004; 42(1):173-81.
16. Lechner M, Lirk P, Rieder J. Inducible Nitric Oxide Syntase (iNOS) in Tumor Biology: Two sides of the
same coin. Semin Cancer Biol. 2005 Aug; 15(4):277-89.
17. Zhang M, Luo B, Chen S J, Abrams G A, Fallon M B. Endothelin-1 Stimulation of Endothelial Nitric
Oxide Synthase in Pathogenesis of Hepatopulmonary Syndrome. Am J Physiol. 1999 Nov; 277(5 pt 1): G
944-52.
18. Tahan V, Avsar E, Karaca C, Uslu E, Eren F. Adrenomedullin in Cirrhotic and Noncirrhotic Portal
Hypertention. World J.Gastroentrol.2003 Oct; 9(10):2325-7.
19. Murray R K, Granner D K, Mayes P A, Rodwell V W. Muscle and the cytoskeleton. Harper’s
Biochemistry, 25th edition; 58; 729-730.

Thank you for copying data from http://www.arastirmax.com